These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3530904)
1. gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant. Roncaglioni MC; Dalessandro AP; Casali B; Vermeer C; Donati MB Haemostasis; 1986; 16(3-4):295-9. PubMed ID: 3530904 [TBL] [Abstract][Full Text] [Related]
2. Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma. Roncaglioni MC; Falanga A; D'Alessandro AP; Alessio MG; Casali B; Donati MB Haematologica; 1989; 74(2):143-7. PubMed ID: 2501168 [TBL] [Abstract][Full Text] [Related]
3. Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin? Donati MB; Roncaglioni MC; Falanga A; Casali B; Semeraro N Haemostasis; 1986; 16(3-4):288-94. PubMed ID: 3530903 [TBL] [Abstract][Full Text] [Related]
4. A comparison between vitamin K-dependent carboxylase from normal and warfarin-treated cows. Vermeer C; Soute BA; De Metz M; Hemker HC Biochim Biophys Acta; 1982 Feb; 714(2):361-5. PubMed ID: 6799008 [TBL] [Abstract][Full Text] [Related]
5. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics. Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610 [TBL] [Abstract][Full Text] [Related]
6. The propeptide of the vitamin K-dependent carboxylase substrate accelerates formation of the gamma-glutamyl carbanion intermediate. Li S; Furie BC; Furie B; Walsh CT Biochemistry; 1997 May; 36(21):6384-90. PubMed ID: 9174354 [TBL] [Abstract][Full Text] [Related]
8. Responses of renal and hepatic vitamin K dependent gamma-glutamyl carboxylase substrates to warfarin and vitamin K treatments. Karl PI; Friedman PA Int J Biochem; 1985; 17(12):1313-6. PubMed ID: 4092815 [TBL] [Abstract][Full Text] [Related]
9. The biochemical basis of warfarin therapy. Suttie JW Adv Exp Med Biol; 1987; 214():3-16. PubMed ID: 3310547 [TBL] [Abstract][Full Text] [Related]
10. Cancer cell procoagulants and their pharmacological modulation. Donati MB; Semeraro N Haemostasis; 1984; 14(5):422-9. PubMed ID: 6398243 [TBL] [Abstract][Full Text] [Related]
11. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues. Kaplinska K; Mielicki WP Blood Coagul Fibrinolysis; 2009 Jul; 20(5):315-20. PubMed ID: 19448531 [TBL] [Abstract][Full Text] [Related]
13. The metabolic role of vitamin K. Suttie JW Fed Proc; 1980 Aug; 39(10):2730-5. PubMed ID: 7409197 [TBL] [Abstract][Full Text] [Related]
14. Glutamyl substrate-induced exposure of a free cysteine residue in the vitamin K-dependent gamma-glutamyl carboxylase is critical for vitamin K epoxidation. Bouchard BA; Furie B; Furie BC Biochemistry; 1999 Jul; 38(29):9517-23. PubMed ID: 10413529 [TBL] [Abstract][Full Text] [Related]
15. Developmental expression of vitamin K-dependent gamma-carboxylase activity in zebrafish embryos: effect of warfarin. Hanumanthaiah R; Thankavel B; Day K; Gregory M; Jagadeeswaran P Blood Cells Mol Dis; 2001; 27(6):992-9. PubMed ID: 11831865 [TBL] [Abstract][Full Text] [Related]
16. Substrate recognition by the vitamin K-dependent gamma-glutamyl carboxylase: identification of a sequence homology between the carboxylase and the carboxylase recognition site in the substrate. Price PA; Williamson MK Protein Sci; 1993 Nov; 2(11):1987-8. PubMed ID: 8268808 [No Abstract] [Full Text] [Related]
17. Defective gamma-glutamyl carboxylase activity and bleeding in Rambouillet sheep. Johnson JS; Soute BA; Olver CS; Baker DC Vet Pathol; 2006 Sep; 43(5):726-32. PubMed ID: 16966451 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Drosophila vitamin K-dependent gamma-glutamyl carboxylase. Li T; Yang CT; Jin D; Stafford DW J Biol Chem; 2000 Jun; 275(24):18291-6. PubMed ID: 10748045 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells. Fasco MJ; Wilson AC; Lincoln D; Gierthy J Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555 [TBL] [Abstract][Full Text] [Related]
20. Vitamin K-dependent carboxylase: mRNA distribution and effects of vitamin K-deficiency and warfarin treatment. Liu Y; Nelson AN; Lipsky JJ Biochem Biophys Res Commun; 1996 Jul; 224(2):549-54. PubMed ID: 8702425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]